UNSPSC 51182026: Ethylestrenol

This classification denotes an anabolic steroid with the molecular formula C20H32O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ADC79EK5Q8, chemically known as 19-norpregn-4-en-17-ol, (17.alpha.)- but generally known as ethylestrenol, which bears US NIH Compound Identifier 3302. European Medicines Agency schedules Ethylestrenol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07291MIG.

UNSPSC 51182026 Ethylestrenol is a Commodity code naming a specific anabolic steroid pharmaceutical product. State and local governments procure ethylestrenol primarily through health and human services agencies, correctional facilities, and public hospitals for medical use in treating muscle wasting, severe anemia, and other approved therapeutic indications. The product is a controlled substance regulated by the DEA and subject to strict dispensing and recordkeeping requirements under state pharmacy boards and federal law. Procurement typically occurs through standing pharmaceutical contracts with state health departments or through individual hospital purchasing departments that maintain formularies and vendor agreements.

The recent state and local contract opportunities block contains no entries for UNSPSC 51182026, indicating minimal or no recent public procurement activity under this code. State and local buyers may consolidate ethylestrenol purchases under broader pharmaceutical supply codes, obtain the product through state cooperative purchasing vehicles (such as state health department master agreements or GPOs), or source it directly from licensed pharmaceutical wholesalers without public solicitation. Without recent RFP, RFQ, IFB, or ITB notices in the data, geographic concentration and specific issuing-body patterns cannot be determined from current market signals.